0.28
0.00%
0.00
Handel nachbörslich:
.29
0.010
+3.57%
Finanzdaten der Oncology Institute Inc-Aktie (TOI)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
10.35%
94.67
|
85.79 | 82.03 | 80.22 | 76.19 |
Operating Expenses
|
11.44%
112.64
|
101.08 | 95.96 | 95.16 | 109.06 |
Benefits Costs and Expenses |
9.25%
114.56
|
104.86 | 99.32 | 97.02 | 106.15 |
Costs And Expenses |
9.25%
114.56
|
104.86 | 99.32 | 97.02 | 106.15 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Depreciation and Amortization |
5.58%
1.489
|
1.577 | 1.698 | 1.329 | 1.269 |
Operating Income/Loss |
17.56%
-17.97
|
-15.29 | -13.93 | -14.94 | -32.87 |
Net Interest Income/Expense |
260.08%
-1.985
|
1.24 | -2.695 | -2.672 | -2.65 |
Nonoperating Income/Loss |
49.29%
-1.917
|
-3.78 | -3.359 | -1.86 | 2.913 |
Income/Loss From Continuing Operations Before Tax |
4.31%
-19.89
|
-19.07 | -17.28 | -16.80 | -29.95 |
Income Tax Expense/Benefit, Deferred |
100.00%
-
|
-0.126 | 0.08 | -0.004 | -0.026 |
Income Tax Expense/Benefit |
100.00%
-
|
-0.314 | 0.135 | 0.099 | 0.044 |
Income/Loss From Continuing Operations After Tax |
6.05%
-19.89
|
-18.75 | -17.42 | -16.90 | -30.00 |
Net Income/Loss
|
6.05%
-19.89
|
-18.75 | -17.42 | -16.90 | -30.00 |
Preferred Stock Dividends And Other Adjustments |
4.30%
-3.617
|
-3.468 | -3.148 | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
107.17K%
74.23
|
0.0692 | 73.47 | 74.12 | 73.45 |
Diluted Average Shares |
107.17K%
74.23
|
0.0692 | 73.47 | 74.12 | 73.45 |
Basic Earnings Per Share |
4.76%
-0.22
|
-0.21 | -0.19 | -0.19 | -0.33 |
Diluted Earnings Per Share |
4.76%
-0.22
|
-0.21 | -0.19 | -0.19 | -0.33 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
4.30%
-3.617
|
-3.468 | -3.148 | -3.077 | -5.504 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):